Abstract |
Umbelliprenin is a prenylated compound, which belongs to the class of sesquiterpene coumarins. In continuation of our earlier in-vitro finding, we determined to assess the cancer chemopreventive activity of umbelliprenin in vivo by using a two-stage carcinogenesis assay of mouse skin tumors induced by peroxynitrite as an initiator and TPA (12-O-tetradecanoylphorbol-13-acetate) as a promoter. In this assay, treatment with umbelliprenin along with peroxynitrite/TPA delayed the formation of papillomas up to week 9, and approximately 33.3 and 86.6% of the mice bore papillomas after 11 and 20 weeks of promotion, respectively. Umbelliprenin reduced the number of tumors per mouse by 45% after 20 weeks of promotion compared with the control group. Interestingly, this is equal to the corresponding value (45%) for curcumin, used as a reference standard compound in our study. In addition, the pattern of tumor promotion was slower in mice treated with umbelliprenin compared with the curcumin. Therefore, umbelliprenin might be valuable as a cancer chemopreventive agent.
|
Authors | Mehrdad Iranshahi, Amirhossein Sahebkar, Midori Takasaki, Takao Konoshima, Harukuni Tokuda |
Journal | European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
(Eur J Cancer Prev)
Vol. 18
Issue 5
Pg. 412-5
(Sep 2009)
ISSN: 1473-5709 [Electronic] England |
PMID | 19531956
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anticarcinogenic Agents
- Carcinogens
- Umbelliferones
- Peroxynitrous Acid
- umbelliprenin
|
Topics |
- Animals
- Anticarcinogenic Agents
(therapeutic use)
- Carcinogens
- Disease Models, Animal
- Female
- Mice
- Papilloma
(chemically induced, prevention & control)
- Peroxynitrous Acid
- Skin Neoplasms
(chemically induced, prevention & control)
- Umbelliferones
(therapeutic use)
|